Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

SOLV - Solventum Corporation Последние новости | Finranks

Home

/

SOLV

S

Solventum Corporation (SOLV)

NYQ – Цена в реальном времени. Валюта: USD

84.32

+0.23 (0.27%)

Рынок открыт: Aug 12, 2026, 12:38 PM EDT

84.10

0.00 (0.00%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Here's Why Solventum (SOLV) is a Strong Momentum Stock

Here's Why Solventum (SOLV) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Solventum Q2 Earnings Call Highlights

Solventum Q2 Earnings Call Highlights

Solventum NYSE: SOLV reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff refund benefit. The company also announced plans to separate its Health Information Systems, or HIS, business as part of a broader effort to sharpen its focus on medical technology markets.

Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates

Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates

SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.

Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript

Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript

Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript

Solventum (SOLV) Q2 Earnings and Revenues Top Estimates

Solventum (SOLV) Q2 Earnings and Revenues Top Estimates

Solventum (SOLV) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $1.69 per share a year ago.

Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Solventum to hive off healthcare software business, raises profit forecast

Solventum to hive off healthcare software business, raises profit forecast

Solventum , one of the largest providers of hospital consumables and sterilization devices, said on Wednesday it is planning to separate its health information systems ‌business as part of its ongoing turnaround strategy.

Видео

No Data

There is no data to display

Пресс-релизы

Solventum Reports Second Quarter 2026 Financial Results

Solventum Reports Second Quarter 2026 Financial Results

Reported sales increased 2.2%; organic sales increased 9.5% Announces intent to separate its Health Information Systems business segment Increases full-year 2026 guidance for organic sales growth, adjusted EPS and free cash flow EAGAN, Minn., Aug. 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.

Solventum Announces Intent to Separate its Health Information Systems Business

Solventum Announces Intent to Separate its Health Information Systems Business

Strengthens the focus of Solventum as a dedicated MedTech company and advances its three-phase transformation strategy Positions Health Information Systems, a leading, scaled, healthcare software business, to accelerate its strategic vision and growth agenda as a separate entity Unlocks shareholder value and enables targeted investment supporting innovation and growth across both businesses EAGAN, Minn., Aug. 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy.